Thursday, November 13, 2008

Wockhardt launches Midazolam in US market

Wockhardt has launched Midazolam injection in the United States after receiving approval from the US FDA for marketing the preservative-free version injections containing 1 mg/ml and 5mg/ml Midazolam, which is used for treating acute insomnia and anxiety.

The details can be read here.

No comments: